Indicação, acesso e utilização de medicamentos para doenças respiratórias crônicas no Brasil: resultados da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos no Brasil (PNAUM), 2014

Leal, Lisiane Freitas; Bertoldi, Andrea Dâmaso; Menezes, Ana Maria Baptista; Borges, Rogério Boff; Mengue, Sotero Serrate; Gazzana, Marcelo Basso; Pizzol, Tatiane da Silva Dal.
Cad. Saúde Pública (Online) ; 34(10): e00208217, oct. 2018. tab, graf
Artigo em Português | LILACS | ID: biblio-952360

Documentos relacionados

  1. [Indication, access, and use of medicines for chronic respiratory diseases in Brazil: results from the National Survey on Access, Utilization, and Promotion of Rational Use of Medicines in Brazil (PNAUM), 2014].
  2. [Disease burden and risk factors of chronic respiratory diseases in Jiangsu Province from 1990 to 2019].
  3. Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease.
  4. Long-term health complications of chemical weapon exposure: a study on Halabja chemical attack survivors (Iraqi Kurds).
  5. Precision medicine in united airways disease: A "treatable traits" approach.
  6. Retrofitting home insulation reduces incidence and severity of chronic respiratory disease.
  7. [Burning of sugarcane biomass and hospitalizations of children and older adults for respiratory problems in Pernambuco State, Brazil].
  8. Climate change and respiratory diseases: a 2020 perspective.
  9. Lessons from Dairy Farmers for Occupational Allergy and Respiratory Disease.
  10. Deployment-Related Respiratory Disease: Where Are We?